2017 has been a year of widespread global attention to blockchain possibilities beyond mere finance, and the PROOF Centre, together with Blockchain@UBC (http://www.blockchainubc.ca/) and other partners, is exploring these applications within the contexts of health research, ethics, privacy, record-keeping, and research design.
Blockchain technology has the potential to expedite research processes and support greater citizen control over personal medical data, through verifiable provenance, pseudonymous security, and math-based trust. However, blockchain protocols are not just about code. The technology is so new that there’s an equal need for practical implementation.
Thus, Blockchain@UBC, PROOF Centre and other industry leaders in blockchain technologies are holding the “Blockathon for Social Good” at UBC's Institute for Computing, Information and Cognitive Systems (ICICS) on Friday, August 4, 2017. Instead of just hunching over individual laptops, this full day Blockathon event will involve diffuse brainstorming, quiet reflection, cross-team discussion and networking. Participants, working in teams, will explore the use of blockchain in solving problems in biomedical research, with use cases provided by PROOF Centre. The winning team will receive a cash prize.
We are inviting all interested biomedical researchers to participate in the Blockathon. You do not need to be a coder or knowledgeable about blockchain technology. As a "domain expert", your knowledge of how health research works will be valuable to participating developers and blockchain experts.
For more information about the Blockathon and to register, please visit:
Learn more about the PROOF Centre's programs in cardiac transplantation at this year's Banff-CST Joint Scientific Meeting. Drs. Bruce McManus and Scott Tebbutt will be presenting during the event.
Wednesday, October 7, 4:30-5:00 p.m.
Leukocyte Transcripts as Biomarkers in Cardiac Transplantation
Dr. Scott Tebbutt, CSO, PROOF Centre of Excellence
Session: Banff Heart Concurrent I & II: Improving Heart Transplant Rejection Diagnostic System: Unmet Needs, Current Limitations, New Implementations and Future Directions
Friday October 9, 2015, 9:00-9:30 a.m.
Biomarkers for Monitoring Cardiac Allograft Rejection: Ready for Prime Time?
Dr. Bruce McManus, CEO, PROOF Centre of Excellence
Session: CST Heart Concurrent Session
The meeting is co-hosted by the Canadian Society of Transplantation and The Banff Foundation for Allograft Pathology and is held in Vancouver, BC from October 5 to 10, 2015.
On September 27-30, Vancouver will host the 14th Human Proteome Organization World Congress (HUPO 2015). This year’s theme is ‘Translating Proteomics and Allied -Omics to the Clinic,’ emphasizes the need for collaboration and cooperation of individuals from a wide range of professional backgrounds
If you are attending the meeting, come by and visit the PROOF Centre table (booth 416) in the exhibit hall.
You can also catch more PROOF Centre members and talks throughout the meeting:
- Drs. Bruce McManus and Mari DeMarco co-organized and are participating in Clinical Day, which takes place on Sunday, September 27.
- Dr. McManus will also be speaking on Tuesday, September 29 in the New Advances in Biomarker Discovery Session. His talk title is Multi-Omic Signatures for Monitoring Patients with Limb-Girdle Muscular Dystrophy.
PROOF Centre will also have two posters at the meeting:
- A Component-Based Classifier Can Diagnose AECOPD by Integrating Across Omics Data Types
Casey P. Shannon, Amrit Singh, Virginia Chen, Zsuzsanna Hollander, Robert Balshaw, Bruce M. McManus, J. Mark FitzGerald, Don D. Sin, Raymond T. Ng, Scott J. Tebbutt
- MRM-Based Proteins Diagnostic of Chronic Obstructive Pulmonary Disease Exacerbations
Zsuzsanna Hollander, Janice M Leung, Virginia Chen, Scott J Tebbutt1, Shawn D Aaron, Kathy L Vandemheen, Stephen I Rennard, Prescott G Woodruff, Stephen C Lazarus, John E Connett, Harvey O Coxson, Christoph H Borchers, Bruce M McManus, Raymond T Ng, Don D Sin
Amrit Singh, Young Woong Kim and Yolanda Yang will also be presenting findings from the asthma and allergy programs.
The Human Proteome Organization (HUPO) is an international scientific organization representing and promoting proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques and training.
We hope we'll see you there!